The Effects of the Obesity Paradox and In-Hospital and One-Year Outcomes in Patients With ST Elevation Myocardial Infarction (STEMI): Results From a STEMI Registry

被引:0
作者
Sharbati, Mina [1 ]
Heidarimoghadam, Reza [1 ]
Rouzbahani, Mohammad [1 ]
Salehi, Nahid [1 ]
Montazeri, Nafiseh [1 ]
Azimivaghar, Javad [1 ]
Mahmoudi, Sousan [1 ]
Rai, Alireza [1 ]
机构
[1] Kermanshah Univ Med Sci, Hlth Inst, Cardiovasc Res Ctr, Kermanshah, Iran
关键词
Myocardial infarction; Registry; BMI; Iran; Obesity; BODY-MASS INDEX; PERCUTANEOUS CORONARY INTERVENTION; CLINICAL-PRACTICE; EXTREME OBESITY; RISK-FACTOR; DISEASE; IMPACT; ASSOCIATION; MORTALITY; WEIGHT;
D O I
10.48305/arya.2022.26592.2811
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Obesity is strongly associated with increased cardiovascular diseases (CVD) and cardiovascular risk factors, such as diabetes mellitus, hypertension, and dyslipidemia. However, numerous studies have suggested the existence of an "obesity paradox" in which overweight and mildly obese patients often exhibit a better outcome than their leaner counterparts. Therefore, this study aimed to characterize the association between BMI and in-hospital and one-year outcomes.METHODS: This hospital-based research was conducted as a part of the Kermanshah STEMI Registry. Following the application of inclusion criteria, a total of 2,397 STEMI patients were evaluated. The data were collected using a standardized case report developed by the European Observational Registry Program (EORP). Body mass index (BMI) (kg/m2) was classified into underweight (<18.5), normal weight (18.5- 24.9), overweight (25-29.9), class I/mild obese (30-34.9), and class II/extreme obese (>= 35) categories. The independent predictors of the in-hospital and one-year outcomes were assessed using multivariable logistic regression models.RESULTS: Out of the 2397 patients, 43 (1.79%) were underweight, 934 (38.97%) were normal, 1038 (43.30%) were overweight, 322 (13.43%) were class I obese, and 60 (2.50%) were class II obese. The results of the crude analysis showed that class I obesity was protective against CV death (OR 0.50; 95% CI 0.300.84), MACE3 (MI, stroke, and death) (OR 0.47; 95% CI 0.29-0.76), and MACE5 (MACE3 plus unstable angina and heart failure) (OR 0.59; 95% CI 0.44-0.79).CONCLUSIONS: Multivariate adjustment eliminated the protective effect of class I obesity against death and MACE events. Therefore, it is possible that this protective effect does not exist and instead reflects the impact of confounding variables such as age.
引用
收藏
页码:89 / 97
页数:9
相关论文
共 21 条
  • [1] Ades PA, 2010, Mayo Clinic Proceedings
  • [2] No Evidence of "Obesity Paradox" After Treatment With Drug-Eluting Stents in a Routine Clinical Practice Results From the Prospective Multicenter German DES.DE (German Drug-Eluting Stent) Registry
    Akin, Ibrahim
    Toelg, Ralph
    Hochadel, Matthias
    Bergmann, Martin W.
    Khattab, Ahmed A.
    Schneider, Steffen
    Senges, Jochen
    Kuck, Karl-Heinz
    Richardt, Gert
    Nienaber, Christoph A.
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2012, 5 (02) : 162 - 169
  • [3] Angeras O., 2012, Eur Heart J
  • [4] Impact of obesity on total and cardiovascular mortality-fat or fiction?
    Cepeda-Valery, Beatriz
    Pressman, Gregg S.
    Figueredo, Vincent M.
    Romero-Corral, Abel
    [J]. NATURE REVIEWS CARDIOLOGY, 2011, 8 (04) : 233 - 237
  • [5] Impact of Body Weight and Extreme Obesity on the Presentation, Treatment, and In-Hospital Outcomes of 50,149 Patients With ST-Segment Elevation Myocardial Infarction
    Das, Sandeep R.
    Alexander, Karen P.
    Chen, Anita Y.
    Powell-Wiley, Tiffany M.
    Diercks, Deborah B.
    Peterson, Eric D.
    Roe, Matthew T.
    de Lemos, James A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (25) : 2642 - 2650
  • [6] The obesity paradox: effect of body mass index on 2-years clinical outcome after primary percutaneous coronary intervention in Indonesia
    Firman, D.
    Arilaksono, D. G.
    Ambari, A. M.
    Radi, B.
    Indriyani, S.
    Siagian, S. N.
    Pranata, R.
    Alkatiri, A. A.
    Iryuza, N.
    Mangkuanom, A. S.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (15) : 4973 - 4982
  • [7] Jaffe AS, 2013, CLIN BIOCHEM, V46, P1, DOI [10.1093/eurheartj/ehs184, 10.1016/j.gheart.2018.08.004, 10.1016/j.clinbiochem.2012.10.036, 10.1016/j.jacc.2012.08.001, 10.5603/KP.2018.0203, 10.1016/j.gheart.2012.08.001, 10.1161/CIR.0b013e31826e1058]
  • [8] Obesity paradox in Japanese patients after percutaneous coronary intervention: An observation cohort study
    Kaneko, Hidehiro
    Yajima, Junji
    Oikawa, Yuji
    Tanaka, Shingo
    Fukamachi, Daisuke
    Suzuki, Shinya
    Sagara, Koichi
    Otsuka, Takayuki
    Matsuno, Shunsuke
    Funada, Ryuichi
    Kano, Hiroto
    Uejima, Tokuhisa
    Koike, Akira
    Nagashima, Kazuyuki
    Kirigaya, Hajime
    Sawada, Hitoshi
    Aizawa, Tadanori
    Yamashita, Takeshi
    [J]. JOURNAL OF CARDIOLOGY, 2013, 62 (1-2) : 18 - 24
  • [9] The Obesity Paradox, Weight Loss, and Coronary Disease
    Lavie, Carl J.
    Milani, Richard V.
    Artham, Surya M.
    Patel, Dharmendrakumar A.
    Ventura, Hector O.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2009, 122 (12) : 1106 - 1114
  • [10] Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss
    Lavie, Carl J.
    Milani, Richard V.
    Ventura, Hector O.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (21) : 1925 - 1932